These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 370507)

  • 1. In vitro assay for responsiveness of lymphocytes to transfer factor by a new leukocyte migration inhibitory test.
    Miyagawa Y; Kawasaki A; Komiyama A; Akabane T
    Microbiol Immunol; 1978; 22(11):701-10. PubMed ID: 370507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.
    Górski AJ; Dupont B; Hansen JA; Good RA
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3197-200. PubMed ID: 1103141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.
    Górski AJ; Dupont B; Hansen JA; O'Reilly R; Smithwick E; Górska R; Good RA
    Clin Exp Immunol; 1976 Dec; 26(3):505-10. PubMed ID: 795576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
    Crivii SM; Crişan M; Crişan M
    Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction.
    Gorski AJ; Dupont B; Hansen JA; Safai B; Pahwa S; Good RA
    J Immunol; 1977 Mar; 118(3):858-62. PubMed ID: 139447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoprofile of LMIF in immunologic deficiency syndromes. II. Mediator production by isolated subpopulations of human lymphocytes].
    Górski A
    Pol Arch Med Wewn; 1978 Apr; 59(4):395-401. PubMed ID: 149303
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunoprofile of LMIF in immunologic deficiency syndromes. I. Lymphocytes suppressing lymphokines in mixed lymphocyte culture].
    Górski A
    Pol Arch Med Wewn; 1978 Apr; 59(4):389-93. PubMed ID: 149302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
    Hashimoto Y; Sekiguchi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte migration inhibitory factor (LMIF) production in unidirectional mixed lymphocyte cultures.
    Górski AJ; Dupont B; Hansen JA; Good RA
    J Immunol; 1976 Sep; 117(3):865-70. PubMed ID: 134123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity against digestive organ cancers : leucocyte migration inhibitory factor activity as an immunological parameter.
    Hamasaki K
    Acta Med Okayama; 1977 Jun; 31(3):147-59. PubMed ID: 144415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of lymphocyte motility by macrophages: characterization of a lymphocyte migration inhibitory factor derived from a macrophage-like cell line.
    Ye S; Cheung HT
    Cell Immunol; 1989 Aug; 122(1):231-43. PubMed ID: 2665945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
    Hahn T; Levin S; Handzel ZT
    Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte migration inhibition test (LMIT) in systemic lupus erythematosus.
    Tanaka K; Yamauchi Y; Horimatsu T; Isobe T; Imura H
    Microbiol Immunol; 1978; 22(12):785-92. PubMed ID: 377031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte migration inhibitory factor in HSV infections.
    Centifanto YM; Zam ZS; McNeill JI; Kaufman HE
    Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):863-8. PubMed ID: 212384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mitogens on leukocyte migration inhibition test in immune deficiency states and influence of transfer factor on response.
    Morison WL
    Proc R Soc Med; 1974 Jun; 67(7):597-8. PubMed ID: 4604389
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the pathogenic mechanism of beta-lactam hypersensitivity by the detection of leucocyte migration activating factor and leucocyte migration inhibitory factor].
    Uno K
    Arerugi; 1990 Dec; 39(12):1605-11. PubMed ID: 2096806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of clinical significance of leukocyte migration inhibition test in drug-induced hypersensitivity pneumonitis].
    Uno K; Kondo A
    Arerugi; 1995 Dec; 44(12):1401-9. PubMed ID: 8871295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. 1. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration.
    Wilson GB; Fudenberg HH; Horsmanheimo M
    J Lab Clin Med; 1979 May; 93(5):800-18. PubMed ID: 429876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer in vivo of tuberculin hypersensitivity by sensitised lymphocytes.
    Fazio M; Calabrese F; Giacomasso S; Meina G; Negri L; Mastromatteo V
    Panminerva Med; 1993 Sep; 35(3):149-53. PubMed ID: 8090529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.